121 related articles for article (PubMed ID: 38048527)
21. 68Ga-PSMA Uptake in Brain Metastasis of Gastric Carcinoma.
Kesim S; Oksuzoglu K
Clin Nucl Med; 2022 Sep; 47(9):e585-e586. PubMed ID: 35930713
[TBL] [Abstract][Full Text] [Related]
22. Frusemide aids diagnostic interpretation of
Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):739-744. PubMed ID: 28623852
[TBL] [Abstract][Full Text] [Related]
23. Head-to-Head Comparison of
Kuten J; Fahoum I; Savin Z; Shamni O; Gitstein G; Hershkovitz D; Mabjeesh NJ; Yossepowitch O; Mishani E; Even-Sapir E
J Nucl Med; 2020 Apr; 61(4):527-532. PubMed ID: 31562225
[No Abstract] [Full Text] [Related]
24. Diagnostic accuracy of [
Mingels C; Bohn KP; Rominger A; Afshar-Oromieh A; Alberts I
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2436-2444. PubMed ID: 35067735
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 18 F-PSMA-1007 PET/CT With 68 Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer.
Chandekar KR; Singh H; Kumar R; Kumar S; Kakkar N; Mittal BR; Singh SK
Clin Nucl Med; 2023 Jan; 48(1):e1-e8. PubMed ID: 36240786
[TBL] [Abstract][Full Text] [Related]
26.
Draulans C; Pos F; Smeenk RJ; Kerkmeijer L; Vogel WV; Nagarajah J; Janssen M; Mai C; Heijmink S; van der Leest M; Zámecnik P; Oyen R; Isebaert S; Maes F; Joniau S; Kunze-Busch M; De Roover R; Defraene G; van der Heide UA; Goffin K; Haustermans K
Pract Radiat Oncol; 2021; 11(3):202-211. PubMed ID: 33941347
[TBL] [Abstract][Full Text] [Related]
27. Delayed 68Ga-PSMA PET/CT Image-Guided Biopsy for Low-Grade Adenocarcinoma in Benign Prostatic Hyperplasia.
Santhosh S; Jeeva G
Clin Nucl Med; 2021 Apr; 46(4):e190-e192. PubMed ID: 33234940
[TBL] [Abstract][Full Text] [Related]
28. Risk of metastatic disease on
Yaxley JW; Raveenthiran S; Nouhaud FX; Samaratunga H; Yaxley WJ; Coughlin G; Yaxley AJ; Gianduzzo T; Kua B; McEwan L; Wong D
BJU Int; 2019 Sep; 124(3):401-407. PubMed ID: 31141284
[TBL] [Abstract][Full Text] [Related]
29. Can PSMA-Targeting PET/CT Be a Valuable Instrument to Assess the Presence of Brain Metastases in Lung Cancer Patients?: A Case Report.
Dall'Armellina S; Cauda S; Duca S; Gasparro M; Racca M
Clin Nucl Med; 2023 Jun; 48(6):e304-e306. PubMed ID: 37083740
[TBL] [Abstract][Full Text] [Related]
30. Prostate adenocarcinoma with mucinous features - is it PSMA avid?
Horsley PJ; Sheehan-Dare G; Mastrocostas K; Fung C; Kneebone A; Eade TN; Emmet L; Lalak A; Hruby G
J Med Imaging Radiat Oncol; 2022 Aug; 66(5):637-640. PubMed ID: 34524723
[TBL] [Abstract][Full Text] [Related]
31. Hürthle Cell Thyroid Adenoma Showing Avid Uptake on 18F-PSMA-1007 PET/CT.
Tang K; Wang Z; Lin J; Zheng X
Clin Nucl Med; 2020 Mar; 45(3):223-224. PubMed ID: 31876816
[TBL] [Abstract][Full Text] [Related]
32. Incidental Detection of Radiotracer Uptake in Spindle Cell Lipoma on 18 F-PSMA PET/CT.
Hod N; Sherf Y; Lantsberg S
Clin Nucl Med; 2022 Oct; 47(10):e663-e665. PubMed ID: 35619205
[TBL] [Abstract][Full Text] [Related]
33.
De Man K; Van Laeken N; Schelfhout V; Fendler WP; Lambert B; Kersemans K; Piron S; Lumen N; Decaestecker K; Fonteyne V; Delrue L; De Vos F; Ost P
Eur Urol; 2022 Nov; 82(5):501-509. PubMed ID: 35690515
[TBL] [Abstract][Full Text] [Related]
34. Follicular Lymphoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.
Kanthan GL; Coyle L; Kneebone A; Schembri GP; Hsiao E
Clin Nucl Med; 2016 Jun; 41(6):500-1. PubMed ID: 26914565
[TBL] [Abstract][Full Text] [Related]
35. Incidental [18F]PSMA-1007 Appendiceal Uptake Mimicking Nodal Disease.
Nawwar AA; Searle J; Lyburn ID
Clin Nucl Med; 2022 Feb; 47(2):166-167. PubMed ID: 34653048
[TBL] [Abstract][Full Text] [Related]
36. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
Kulkarni SC; Sundaram PS; Padma S
Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366
[TBL] [Abstract][Full Text] [Related]
37. Focal PSMA-Positive Pleural Lesion in a Patient With Stage II Prostate Carcinoma.
Lensing RJ; Broos WAM; van der Zant FM; Knol RJJ
Clin Nucl Med; 2022 Feb; 47(2):e170-e171. PubMed ID: 35006116
[TBL] [Abstract][Full Text] [Related]
38. Optimal Time Point for 68Ga-PSMA-11 PET/CT Imaging in the Assessment of Suspected Metastatic Prostate Cancer in the Bladder of Postprostatectomy Patient.
Xu G; Lu Y
Clin Nucl Med; 2021 Aug; 46(8):675-676. PubMed ID: 33577202
[TBL] [Abstract][Full Text] [Related]
39. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
40. Matched-Pair Comparison of
Rauscher I; Krönke M; König M; Gafita A; Maurer T; Horn T; Schiller K; Weber W; Eiber M
J Nucl Med; 2020 Jan; 61(1):51-57. PubMed ID: 31253741
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
